Cores facility
Our research unit is closely linked to several cores facility that have been created by different members of our unit Most of the scientific and technical leaders of these platforms are BRIC members. The CellOxia, CRISP edit, Histopathology, OncoProt, Vivoptic, and Vect’UB platforms are affiliated with the UAR TBMCore. (Inserm US 05, CNRS UAR 3427, Université de Bordeaux).
- The hypoxia core facility, CellOxia was created by Team 10 – Normal and leukemic hematopoietic stem cells, led by Jean-Max Pasquet
The scientific manager of the platform is Jean-Max Pasquet. The technical manager of the platform is Arnaud Villacreces.
Link : https://www.tbmcore.cnrs.fr/celloxia/
- The CRISP’edit core facility was created by Team 11 – Modeling Transformation and resistance in leukemia, led by Catherine Sawai.
The scientific manager of the core facility is Béatrice Turcq The technical manager of the platform is Valérie Prouzet-Mauleon.
Link : https://www.tbmcore.cnrs.fr/crisp-edit/
- The Histopathology core facility was created by Team 03 – Liver Cancers and Tumor Invasion, led by Violaine Moreau and Frederic Saltel. Pierre Dubus (team 4), Brigitte Le bail (team 3), and Béatrice Turcq (team 11) are members of the Scientific Committee The technical manager of the core facility is Nathalie Dugot-Senant.
Link : https://www.tbmcore.cnrs.fr/histopathologie-bordeaux/
- The proteomic analysis core facility, OncoProt, was created by Team 03 – Liver Cancers and Tumor Invasion, led by Violaine Moreau and Frederic Saltel
The scientific manager of the platform is Frederic Saltel, and the technical manager is Anne-Aurélie Raymond.
Link : https://www.tbmcore.cnrs.fr/oncoprot/
- The POETIC platform, created by the ARTiSt group (co-directed by Delphine Fessart and Frederic Delom) in 2019 and attached to the U1312 BRIC, is a miniaturized high-throughput screening platform. This platform performs large-scale drug tests and studies the impact of protein depletion and/or overexpression. It can be used to follow cell growth, cell death, cell proliferation, toxicity tests, senescence tests, etc.
The Scientific Director of the platform is Delphine Fessart and the Financial Director is Frederic Delom.
- The vectorology core facility, Vect’UB, was created by Team 08 – Biotherapies Genetics and Oncology (BioGO), led by Sandrine Dabernat and François Moreau-Gaudry. The scientific manager of the platform is François Moreau-Gaudry.
The technical manager of the platform is Véronique Guyonnet-Dupérat.
Link : https://www.tbmcore.cnrs.fr/vectorologie-bordeaux/
- The Vivoptic core facility was created by the IMOTION team that joined team 04 – Helicobacter-associated digestive cancers, cancer stem cells and therapeutic strategies, led by Christine Varon. Franck Couillaud and Christine Varon are part of the scientific committee. The technical manager is Coralie Genevois.
Link : https://www.tbmcore.cnrs.fr/vivoptic/
- The Xenopus model platform, Xen’UB, was created by Team 05 – Translational Research In Oncodermatology and Orphan skin diseases (TRIO2), led by Hamid-Reza Rezvani and Marie Beylot-Barry The scientific manager of the platform is Pierre Thiébaud. The technical manager is Sandrine Fedou.
- The zebrafish model platform, Zebrafish was created by team 02 – Reprograming tumor activitY and associaTed MicroenvironmEnt (Rytme), led by A. Majid Khatib and Frederic Delom. The scientific manager of the platform is Géraldine Siegfried.
Spin off
Supported by the Nouvelle-Aquitaine Region, the “technology transfer unit” scheme of Adera (Association for the Development of Teaching and Research at Universities, Research Centres, and Companies in Aquitaine) consists of creating Adera departments attached to public laboratories.
Objective: to meet the technological needs of companies by developing the know-how and equipment of laboratories in the form of services: audits, studies, analyses, training, implementation of innovation projects, etc.
- AquiDerm is the technology transfer structure of the team 05 – Translational Research In Oncodermatology and Orphan skin diseases (TRIO2), led by Hamid-Reza Rezvani and Marie Beylot-Barry The scientific manager of the platform is Hamid-Reza Rezvani, co-managers are Jérôme Rambert and Muriel Cario. The scientific expert is Alain Taieb
It is administratively attached to ADERA.
Link : http://www.aquiderm.com/
